guest ::
| Home > Publications database > Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages. > print |
| Home > Publications database > Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages. > print |
| 001 | 182900 | ||
| 005 | 20240229145735.0 | ||
| 024 | 7 | _ | |a 10.1158/0008-5472.CAN-22-0076 |2 doi |
| 024 | 7 | _ | |a pmid:36200806 |2 pmid |
| 024 | 7 | _ | |a 0008-5472 |2 ISSN |
| 024 | 7 | _ | |a 0099-7013 |2 ISSN |
| 024 | 7 | _ | |a 0099-7374 |2 ISSN |
| 024 | 7 | _ | |a 1538-7445 |2 ISSN |
| 024 | 7 | _ | |a altmetric:136864076 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2022-03003 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Alsina-Sanchis, Elisenda |0 0000-0002-5761-632X |b 0 |e First author |
| 245 | _ | _ | |a Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages. |
| 260 | _ | _ | |a Philadelphia, Pa. |c 2022 |b AACR |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1670841218_24789 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A270#LA:A270# |
| 520 | _ | _ | |a Epithelial ovarian cancer (EOC) is one of the most lethal gynecologic cancers worldwide. EOC cells educate tumor-associated macrophages (TAM) through CD44-mediated cholesterol depletion to generate an immunosuppressive tumor microenvironment (TME). In addition, tumor cells frequently activate Notch1 receptors on endothelial cells (EC) to facilitate metastasis. However, further work is required to establish whether the endothelium also influences the education of recruited monocytes. Here, we report that canonical Notch signaling through RBPJ in ECs is an important player in the education of TAMs and EOC progression. Deletion of Rbpj in the endothelium of adult mice reduced infiltration of monocyte-derived macrophages into the TME of EOC and prevented the acquisition of a typical TAM gene signature; this was associated with stronger cytotoxic activity of T cells and decreased tumor burden. Mechanistically, CXCL2 was identified as a novel Notch/RBPJ target gene that regulated the expression of CD44 on monocytes and subsequent cholesterol depletion of TAMs. Bioinformatic analysis of ovarian cancer patient data showed that increased CXCL2 expression is accompanied by higher expression of CD44 and TAM education. Together, these findings indicate that EOC cells induce the tumor endothelium to secrete CXCL2 to establish an immunosuppressive microenvironment.Endothelial Notch signaling favors immunosuppression by increasing CXCL2 secretion to stimulate CD44 expression in macrophages, facilitating their education by tumor cells. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a Cholesterol |0 97C5T2UQ7J |2 NLM Chemicals |
| 650 | _ | 7 | |a RBPJ protein, human |2 NLM Chemicals |
| 650 | _ | 7 | |a Immunoglobulin J Recombination Signal Sequence-Binding Protein |2 NLM Chemicals |
| 650 | _ | 7 | |a Rbpj protein, mouse |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Tumor-Associated Macrophages |2 MeSH |
| 650 | _ | 2 | |a Endothelial Cells: pathology |2 MeSH |
| 650 | _ | 2 | |a Carcinoma, Ovarian Epithelial: genetics |2 MeSH |
| 650 | _ | 2 | |a Ovarian Neoplasms: pathology |2 MeSH |
| 650 | _ | 2 | |a Tumor Microenvironment |2 MeSH |
| 650 | _ | 2 | |a Endothelium: metabolism |2 MeSH |
| 650 | _ | 2 | |a Cholesterol |2 MeSH |
| 650 | _ | 2 | |a Immunoglobulin J Recombination Signal Sequence-Binding Protein: genetics |2 MeSH |
| 700 | 1 | _ | |a Mülfarth, Ronja |0 P:(DE-He78)3d2b0a3563ccf6bc6ee65cf2976efe5f |b 1 |e First author |
| 700 | 1 | _ | |a Moll, Iris |0 P:(DE-He78)68d90eb013f51c689f9ebea83a920858 |b 2 |
| 700 | 1 | _ | |a Böhn, Sarah Verena |0 P:(DE-He78)289be1a18d5b28404f113c40bbd76578 |b 3 |
| 700 | 1 | _ | |a Wiedmann, Lena |0 P:(DE-He78)b27922c32bcdf07ca4d5f13ecdcfd100 |b 4 |
| 700 | 1 | _ | |a Jordana-Urriza, Lorea |0 0000-0003-2323-817X |b 5 |
| 700 | 1 | _ | |a Ziegelbauer, Tara |0 P:(DE-He78)0b08760d6f32b6f049214b4231328692 |b 6 |
| 700 | 1 | _ | |a Zimmer, Eleni |0 P:(DE-He78)dd8afdb992341efdf1a1ce54d15e65f3 |b 7 |
| 700 | 1 | _ | |a Taylor, Jacqueline |0 P:(DE-He78)df29352b13734f9202e3b900aeef7754 |b 8 |
| 700 | 1 | _ | |a De Angelis Rigotti, Francesca |0 P:(DE-He78)95d56cbcb8b1bb5783526d136049e3df |b 9 |
| 700 | 1 | _ | |a Stögbauer, Adrian |0 P:(DE-He78)2df93ebfdc67577592330aa9c4cfad56 |b 10 |
| 700 | 1 | _ | |a Giaimo, Benedetto Daniele |0 0000-0003-0384-325X |b 11 |
| 700 | 1 | _ | |a Cerwenka, Adelheid |b 12 |
| 700 | 1 | _ | |a Borggrefe, Tilman |0 0000-0003-4325-5452 |b 13 |
| 700 | 1 | _ | |a Fischer, Andreas |0 P:(DE-He78)039283a5d51058ec79156d0ef67132da |b 14 |e Last author |
| 700 | 1 | _ | |a Rodriguez-Vita, Juan |0 0000-0001-9547-5508 |b 15 |e Last author |
| 773 | _ | _ | |a 10.1158/0008-5472.CAN-22-0076 |g Vol. 82, no. 23, p. 4414 - 4428 |0 PERI:(DE-600)2036785-5 |n 23 |p 4414 - 4428 |t Cancer research |v 82 |y 2022 |x 0008-5472 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:182900 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 0000-0002-5761-632X |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)3d2b0a3563ccf6bc6ee65cf2976efe5f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)68d90eb013f51c689f9ebea83a920858 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)289be1a18d5b28404f113c40bbd76578 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)b27922c32bcdf07ca4d5f13ecdcfd100 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 0000-0003-2323-817X |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)0b08760d6f32b6f049214b4231328692 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)dd8afdb992341efdf1a1ce54d15e65f3 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)df29352b13734f9202e3b900aeef7754 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)95d56cbcb8b1bb5783526d136049e3df |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)2df93ebfdc67577592330aa9c4cfad56 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)039283a5d51058ec79156d0ef67132da |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 0000-0001-9547-5508 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-12 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER RES : 2021 |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-12 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-12 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b CANCER RES : 2021 |d 2022-11-12 |
| 920 | 2 | _ | |0 I:(DE-He78)A270-20160331 |k A270 |l A270 Vaskuläre Signaltransduktion und Krebs |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A270-20160331 |k A270 |l A270 Vaskuläre Signaltransduktion und Krebs |x 0 |
| 920 | 0 | _ | |0 I:(DE-He78)A270-20160331 |k A270 |l A270 Vaskuläre Signaltransduktion und Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A270-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|